[
  {
    "projectName": "Immunotherapy Advances",
    "researchField": "Oncology",
    "leadInstitution": "Johns Hopkins University",
    "startDate": "2022-03-01",
    "endDate": "2025-12-31",
    "funding": {
      "totalAmount": 5000000,
      "sources": [
        {
          "name": "National Cancer Institute",
          "amount": 3000000
        },
        {
          "name": "Pharmaceutical Company X",
          "amount": 2000000
        },
        {
          "name": "American Cancer Society",
          "amount": 1000000
        }
      ]
    },
    "researchTeam": [
      {
        "name": "Dr. Jane Smith",
        "role": "Principal Investigator",
        "specialty": "Immunotherapy"
      },
      {
        "name": "Dr. John Doe",
        "role": "Co-Investigator",
        "specialty": "Molecular Biology"
      },
      {
        "name": "Dr. Emily Davis",
        "role": "Data Scientist",
        "specialty": "Biostatistics"
      }
    ],
    "milestones": [
      {
        "name": "Phase 1 Clinical Trials",
        "completionDate": "2023-06-30",
        "status": "Completed"
      },
      {
        "name": "Phase 2 Clinical Trials",
        "completionDate": "2024-12-31",
        "status": "Ongoing"
      },
      {
        "name": "Final Report Submission",
        "completionDate": "2025-12-31",
        "status": "Pending"
      }
    ],
    "publications": [
      {
        "title": "Efficacy of New Immunotherapy in Early-Stage Oncology",
        "journal": "Journal of Clinical Oncology",
        "publicationDate": "2023-09-15",
        "doi": "10.1200/JCO.22.00467"
      },
      {
        "title": "Advances in Molecular Biology for Cancer Treatment",
        "journal": "Nature Medicine",
        "publicationDate": "2024-04-10",
        "doi": "10.1038/s41591-024-00045-6"
      }
    ],
    "clinicalTrials": [
      {
        "trialName": "Immunotherapy Trial A",
        "phase": "Phase 1",
        "startDate": "2023-01-01",
        "endDate": "2023-06-30",
        "totalParticipants": 150,
        "status": "Completed"
      },
      {
        "trialName": "Immunotherapy Trial B",
        "phase": "Phase 2",
        "startDate": "2024-01-01",
        "endDate": "2024-12-31",
        "totalParticipants": 250,
        "status": "Ongoing"
      },
      {
        "trialName": "Immunotherapy Trial C",
        "phase": "Phase 3",
        "startDate": "2025-01-01",
        "endDate": "2025-12-31",
        "totalParticipants": 400,
        "status": "Pending"
      }
    ]
  },
  {
    "projectName": "Neurodegenerative Disease Prevention",
    "researchField": "Neurology",
    "leadInstitution": "Harvard Medical School",
    "startDate": "2021-05-15",
    "endDate": "2024-11-30",
    "funding": {
      "totalAmount": 7500000,
      "sources": [
        {
          "name": "National Institutes of Health",
          "amount": 5000000
        },
        {
          "name": "Alzheimer's Association",
          "amount": 1500000
        },
        {
          "name": "Michael J. Fox Foundation",
          "amount": 1000000
        }
      ]
    },
    "researchTeam": [
      {
        "name": "Dr. Alice Green",
        "role": "Principal Investigator",
        "specialty": "Neurology"
      },
      {
        "name": "Dr. Robert Lee",
        "role": "Co-Investigator",
        "specialty": "Neuroscience"
      },
      {
        "name": "Dr. Lisa Wong",
        "role": "Data Scientist",
        "specialty": "Bioinformatics"
      }
    ],
    "milestones": [
      {
        "name": "Initial Biomarker Discovery",
        "completionDate": "2022-12-31",
        "status": "Completed"
      },
      {
        "name": "Phase 1 Clinical Trials",
        "completionDate": "2023-09-30",
        "status": "Completed"
      },
      {
        "name": "Final Analysis and Reporting",
        "completionDate": "2024-11-30",
        "status": "Pending"
      }
    ],
    "publications": [
      {
        "title": "Biomarkers for Early Detection of Alzheimerâ€™s Disease",
        "journal": "Alzheimer's & Dementia",
        "publicationDate": "2023-02-20",
        "doi": "10.1016/j.jalz.2023.01.002"
      },
      {
        "title": "Advances in Neurodegenerative Disease Prevention",
        "journal": "Lancet Neurology",
        "publicationDate": "2024-07-15",
        "doi": "10.1016/S1474-4422(24)00234-9"
      }
    ],
    "clinicalTrials": [
      {
        "trialName": "Neuroprotective Agent Trial 1",
        "phase": "Phase 1",
        "startDate": "2022-06-01",
        "endDate": "2023-09-30",
        "totalParticipants": 200,
        "status": "Completed"
      },
      {
        "trialName": "Neuroprotective Agent Trial 2",
        "phase": "Phase 2",
        "startDate": "2023-12-01",
        "endDate": "2024-11-30",
        "totalParticipants": 350,
        "status": "Ongoing"
      },
      {
        "trialName": "Neuroprotective Agent Trial 3",
        "phase": "Phase 3",
        "startDate": "2024-12-01",
        "endDate": "2025-11-30",
        "totalParticipants": 500,
        "status": "Pending"
      }
    ]
  },
  {
    "projectName": "Diabetes Management Innovations",
    "researchField": "Endocrinology",
    "leadInstitution": "University of Cambridge",
    "startDate": "2020-01-01",
    "endDate": "2023-12-31",
    "funding": {
      "totalAmount": 4500000,
      "sources": [
        {
          "name": "Wellcome Trust",
          "amount": 2000000
        },
        {
          "name": "Juvenile Diabetes Research Foundation",
          "amount": 1500000
        },
        {
          "name": "European Research Council",
          "amount": 1000000
        }
      ]
    },
    "researchTeam": [
      {
        "name": "Dr. Michael Brown",
        "role": "Principal Investigator",
        "specialty": "Endocrinology"
      },
      {
        "name": "Dr. Susan White",
        "role": "Co-Investigator",
        "specialty": "Diabetes Research"
      },
      {
        "name": "Dr. David Black",
        "role": "Data Scientist",
        "specialty": "Biostatistics"
      }
    ],
    "milestones": [
      {
        "name": "Development of New Insulin Formulation",
        "completionDate": "2021-06-30",
        "status": "Completed"
      },
      {
        "name": "Phase 1 Clinical Trials",
        "completionDate": "2022-08-31",
        "status": "Completed"
      },
      {
        "name": "Market Readiness Assessment",
        "completionDate": "2023-12-31",
        "status": "Pending"
      }
    ],
    "publications": [
      {
        "title": "Innovations in Diabetes Management",
        "journal": "Diabetes Care",
        "publicationDate": "2022-11-10",
        "doi": "10.2337/dc22-0934"
      },
      {
        "title": "Advances in Insulin Delivery Methods",
        "journal": "Nature Reviews Endocrinology",
        "publicationDate": "2023-04-18",
        "doi": "10.1038/s41574-023-00578-1"
      }
    ],
    "clinicalTrials": [
      {
        "trialName": "Insulin Formulation Trial 1",
        "phase": "Phase 1",
        "startDate": "2021-07-01",
        "endDate": "2022-08-31",
        "totalParticipants": 100,
        "status": "Completed"
      },
      {
        "trialName": "Insulin Formulation Trial 2",
        "phase": "Phase 2",
        "startDate": "2022-09-01",
        "endDate": "2023-12-31",
        "totalParticipants": 250,
        "status": "Ongoing"
      },
      {
        "trialName": "Insulin Formulation Trial 3",
        "phase": "Phase 3",
        "startDate": "2024-01-01",
        "endDate": "2024-12-31",
        "totalParticipants": 400,
        "status": "Pending"
      }
    ]
  },
  {
    "projectName": "Advanced Vaccines for Emerging Viruses",
    "researchField": "Virology",
    "leadInstitution": "University of Oxford",
    "startDate": "2022-01-01",
    "endDate": "2025-12-31",
    "funding": {
      "totalAmount": 10000000,
      "sources": [
        {
          "name": "Gates Foundation",
          "amount": 5000000
        },
        {
          "name": "World Health Organization",
          "amount": 3000000
        },
        {
          "name": "UK Government",
          "amount": 2000000
        }
      ]
    },
    "researchTeam": [
      {
        "name": "Dr. Thomas Grey",
        "role": "Principal Investigator",
        "specialty": "Virology"
      },
      {
        "name": "Dr. Amanda Blue",
        "role": "Co-Investigator",
        "specialty": "Immunology"
      },
      {
        "name": "Dr. Christopher Red",
        "role": "Data Scientist",
        "specialty": "Bioinformatics"
      }
    ],
    "milestones": [
      {
        "name": "Vaccine Candidate Development",
        "completionDate": "2023-03-31",
        "status": "Completed"
      },
      {
        "name": "Phase 1 Clinical Trials",
        "completionDate": "2023-12-31",
        "status": "Ongoing"
      },
      {
        "name": "Phase 2 Clinical Trials",
        "completionDate": "2025-12-31",
        "status": "Pending"
      }
    ],
    "publications": [
      {
        "title": "Efficacy of New Vaccines Against Emerging Viruses",
        "journal": "Vaccine",
        "publicationDate": "2023-07-20",
        "doi": "10.1016/j.vaccine.2023.07.034"
      },
      {
        "title": "Innovations in Vaccine Delivery Systems",
        "journal": "Lancet Infectious Diseases",
        "publicationDate": "2024-02-11",
        "doi": "10.1016/S1473-3099(24)00345-7"
      }
    ],
    "clinicalTrials": [
      {
        "trialName": "Vaccine Candidate Trial 1",
        "phase": "Phase 1",
        "startDate": "2023-04-01",
        "endDate": "2023-12-31",
        "totalParticipants": 300,
        "status": "Ongoing"
      },
      {
        "trialName": "Vaccine Candidate Trial 2",
        "phase": "Phase 2",
        "startDate": "2024-01-01",
        "endDate": "2025-12-31",
        "totalParticipants": 500,
        "status": "Pending"
      },
      {
        "trialName": "Vaccine Candidate Trial 3",
        "phase": "Phase 3",
        "startDate": "2026-01-01",
        "endDate": "2027-12-31",
        "totalParticipants": 1000,
        "status": "Pending"
      }
    ]
  },
  {
    "projectName": "Regenerative Medicine for Spinal Cord Injuries",
    "researchField": "Regenerative Medicine",
    "leadInstitution": "Stanford University",
    "startDate": "2023-04-01",
    "endDate": "2026-06-30",
    "funding": {
      "totalAmount": 8000000,
      "sources": [
        {
          "name": "California Institute for Regenerative Medicine",
          "amount": 5000000
        },
        {
          "name": "Christopher & Dana Reeve Foundation",
          "amount": 2000000
        },
        {
          "name": "Private Donors",
          "amount": 1000000
        }
      ]
    },
    "researchTeam": [
      {
        "name": "Dr. James White",
        "role": "Principal Investigator",
        "specialty": "Regenerative Medicine"
      },
      {
        "name": "Dr. Clara Black",
        "role": "Co-Investigator",
        "specialty": "Neurosurgery"
      },
      {
        "name": "Dr. Mark Green",
        "role": "Data Scientist",
        "specialty": "Biostatistics"
      }
    ],
    "milestones": [
      {
        "name": "Stem Cell Therapy Development",
        "completionDate": "2024-09-30",
        "status": "Ongoing"
      },
      {
        "name": "Phase 1 Clinical Trials",
        "completionDate": "2025-06-30",
        "status": "Pending"
      },
      {
        "name": "Phase 2 Clinical Trials",
        "completionDate": "2026-06-30",
        "status": "Pending"
      }
    ],
    "publications": [
      {
        "title": "Stem Cell Therapy for Spinal Cord Injury",
        "journal": "Nature Medicine",
        "publicationDate": "2024-12-01",
        "doi": "10.1038/s41591-024-00089-6"
      },
      {
        "title": "Regenerative Approaches to Spinal Cord Repair",
        "journal": "Lancet Neurology",
        "publicationDate": "2025-08-25",
        "doi": "10.1016/S1474-4422(25)00123-4"
      }
    ],
    "clinicalTrials": [
      {
        "trialName": "Stem Cell Therapy Trial 1",
        "phase": "Phase 1",
        "startDate": "2024-10-01",
        "endDate": "2025-06-30",
        "totalParticipants": 100,
        "status": "Pending"
      },
      {
        "trialName": "Stem Cell Therapy Trial 2",
        "phase": "Phase 2",
        "startDate": "2025-07-01",
        "endDate": "2026-06-30",
        "totalParticipants": 250,
        "status": "Pending"
      },
      {
        "trialName": "Stem Cell Therapy Trial 3",
        "phase": "Phase 3",
        "startDate": "2026-07-01",
        "endDate": "2027-06-30",
        "totalParticipants": 500,
        "status": "Pending"
      }
    ]
  }
]
